Skip to main content

Advertisement

SpringerLink
Log in

Engagement process for patients with spondyloarthritis: PANLAR early SpA clinics project — centers of excellence

  • Perspectives in Rheumatology
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Spondyloarthritis (SpA) is one of the most complex rheumatological diseases to diagnose and treat because, in the early stages of the disease, the inflammatory low back pain is often difficult to identify, and patients are diagnosed when they already have advanced structural processes. There is an urgent need to establish healthcare models that allow optimization of the management of these patients. The objective of this work is to propose a care model that is adaptable to the factual realities of Latin America. A systematic search of the literature terms (MeSH) was performed to search associated terms. Taking the model of the REAL-PANLAR project as an example and incorporating some related literature, a model of centers of excellence for SpA in Latin America is proposed that can be reasonably established and implemented. This model proposes 3 types of centers of excellence for SpA according to the level of complexity of each institution, and its criteria are defined based on indicators of structure, processes, and results. This is the first effort in Latin America to try to standardize the care of patients with spondyloarthritis.

Key Points

• The unmet needs in Latin America in the care of SpondyloArthritis (SpA), demand solutions that facilitate the rapid and assertive access of patients to specialized centers such as Center of Excellence in SpA.

• This project facilitates the standardization of high-quality care for patients with SpA, starting from its diagnosis and up to clinical follow-up.

• Due to standardization of care, better clinical and safety outcomes are achieved for patients, as well as patient-reported outcomes.

• By standardized models of care, will be achieved a reduction in the progress of this pathology and optimization in the use of high-complexity services and high-cost therapies, improving cost-efficiency for public health systems in each country.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Stolwijk C, van Onna M, Boonen A, van Tubergen A (2016) Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis. Arthritis Care Res 68:1320–1331

    Article  Google Scholar 

  2. Bautista-Molano W, Landewé R, Burgos-Vargas R et al (2018) Prevalence of comorbidities and risk factors for comorbidities in patients with spondyloarthritis in Latin America: a comparative study with the general population and data from the ASAS-COMOSPA study. J Rheumatol 45:206–212

    Article  PubMed  Google Scholar 

  3. Peláez-Ballestas I, Navarro-Zarza JE, Julian B, Lopez A et al (2013) A community-based study on the prevalence of spondyloarthritis and inflammatory back pain in Mexicans. J Clin Rheumatol 19(2):57–61

    Article  PubMed  Google Scholar 

  4. Bellomio V, Berman A, Sueldo R et al (2008) Registro Iberoamericano de Espondiloartritis (RESPONDIA): Argentina. Reumatol Clin 4(Supl E4):23-94: S23

    Google Scholar 

  5. Bautista-Molano W, Landewe RB, Londono J et al (2016) Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritis. Clin Rheumatol 35:1759–1767

    Article  PubMed  Google Scholar 

  6. Ribeiro SLE, de Campos APB, Palominos PE et al (2019) (2018) Different ethnic background is associated with distinct clinical profiles in the spondyloarthritides in the North and South of Brazil. Clin Rheumatol 38(1):195–203

    Article  PubMed  Google Scholar 

  7. Citera G, Bautista-Molano W, Peláez-Ballestas I et al (2021) Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis. Adv Rheumatol 61(1):2

    Article  PubMed  Google Scholar 

  8. Santos-Moreno P, Caballero-Uribe CV, Cardiel MH et al (2019) A consensus position paper from REAL-PANLAR group about the methodological approach for the accreditation process of centers of excellence in rheumatoid arthritis in Latin America. J Clin Rheumatol 25(1):54–58

    Article  PubMed  Google Scholar 

  9. García Salinas R, Ruta S, Chichande JT et al (2021) “Reuma-Check”: Performance of a comprehensive fast-track program for the diagnosis of axial spondyloarthritis in South America. J Clin Rheumatol. https://doi.org/10.1097/RHU.0000000000001654

  10. Sepriano A, Rubio R, Ramiro S et al (2017) Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis. Ann Rheum Dis 76(5):886–890

    Article  PubMed  Google Scholar 

  11. Taurog JD, Chhabra A (2016) Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563–2574

    Article  PubMed  Google Scholar 

  12. Molto A, Sieper J (2018) Peripheral spondyloarthritis: concept, diagnosis and treatment. Best Pract Res Clin Rheumatol 32(3):357–368

    Article  PubMed  Google Scholar 

  13. Rudwaleit M, van der Heijde D, Khan MA et al (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63(5):535–543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sieper J, Rudwaleit M, Baraliakos X (2009) The Assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:ii1–ii44

    Article  PubMed  Google Scholar 

  15. van den Berg R, de Hooge M, Rudwaleit M et al (2013) ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis International Society (ASAS)-cohort. Ann Rheum Dis 72(10):1646–1653

    Article  PubMed  Google Scholar 

  16. Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673

    Article  PubMed  Google Scholar 

  17. Rudwaleit M, van der Heijde D, Landewé R et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25–31

    Article  CAS  PubMed  Google Scholar 

  18. Smolen JS, Schöls M, Braun J et al (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis 77(1):3–17

    Article  PubMed  Google Scholar 

  19. van der Heijde D, Lie E, Kvien TK et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68(12):1811–1818

    Article  PubMed  Google Scholar 

  20. Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–91

    CAS  PubMed  Google Scholar 

  21. Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285

    CAS  PubMed  Google Scholar 

  22. Heuft-Dorenbosch L, Spoorenberg A, Van Tubergen A et al (2013) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62(2):127–132

    Article  Google Scholar 

  23. van der Heijde D, Landewé R, Feldtkeller E (2008) Proposal of a linear definition of the Bath Ankylosing Spondylitis Metrology Index (BASMI) and comparison with the 2-step and 10-step definitions. Ann Rheum Dis 67(4):489–493

    Article  PubMed  Google Scholar 

  24. Kiltz U, van der Heijde D, Boonen A et al (2018) Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Ann Rheum Dis 77(9):1311–1317

    Article  PubMed  Google Scholar 

  25. Kiltz U, van der Heijde D, Boonen A et al (2014) Translation and cross-cultural adaptation of the ASAS Health Index and the environmental item set into 15 languages. Ann Rheum Dis 73(Suppl2):463

    Google Scholar 

  26. Smolen JS, Schoels M, Aletaha D (2015) Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review Clin Exp Rheumatol 33(5 Suppl 93):S48-50

    PubMed  Google Scholar 

  27. Coates LC, FitzGerald O, Merola JF et al (2018) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology consensus-based recommendations and research agenda for use of composite measures and treatment targets in psoriatic arthritis. Arthritis Rheumatol 70(3):345–355

    Article  PubMed  Google Scholar 

  28. Mattei PL, Corey KC, Kimball AB (2014) Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol 28(3):333–337

    Article  CAS  PubMed  Google Scholar 

  29. van der Heijde D, Ramiro S, Landewé R et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991

    Article  PubMed  Google Scholar 

  30. Gratacós J, Del Campo D, Fontecha P, Fernández-Carballido C et al (2018) Recommendations by the Spanish Society of Rheumatology on the use of biological therapies in axial spondyloarthritis. Reumatol Clin 14(6):320–333

    Article  PubMed  Google Scholar 

  31. Torre Alonso JC, Del Campo D, Fontecha P, Almodóvar R et al (2018) Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis. Reumatol Clin 14(5):254–268

    Article  PubMed  Google Scholar 

  32. Coates LC, Kavanaugh A, Mease PJ et al (2016) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015. Treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 68(5):1060–71

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Julián Sucerquia, MD Esp, for his contribution to the design of the graphs and tables and some contributions to the manuscript.

Author information

Authors and Affiliations

  1. Biomab IPS, Bogota, Colombia

    Pedro Santos-Moreno

  2. Rheumazentrum Ruhrgebiet Herne, Ruhr-University, Bochum, Germany

    Xenofon Baraliakos

  3. Unidad de Reumatología, Hospital Italiano de La Plata, Buenos Aires, Argentina

    Rodrigo García-Salinas

Authors
  1. Pedro Santos-Moreno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xenofon Baraliakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rodrigo García-Salinas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pedro Santos-Moreno.

Ethics declarations

Competing interests

PSM has received fees for conferences, counseling, advisory boards, expenses for travel to academic meetings and research grants from AbbVie, Abbott, Biopas-UCB, Bristol, Janssen, Pfizer, Roche, and Sanofi. RGS has received fees for conferences, counseling, advisory boards, academic meeting expenses, and research grants from AbbVie, Bristol, Janssen, Pfizer, and Roche. XB reports consultancy or speaker fees from AbbVie, BMS, Celgene, Chugai, Hexal, Galapagos, Janssen, Lilly, MSD, Novartis, Pfizer, Sandoz, Sanofi, and UCB Pharma.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Santos-Moreno, P., Baraliakos, X. & García-Salinas, R. Engagement process for patients with spondyloarthritis: PANLAR early SpA clinics project — centers of excellence . Clin Rheumatol 40, 4759–4766 (2021). https://doi.org/10.1007/s10067-021-05806-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-021-05806-4

Keywords

Search

Navigation